Adaptive Biotechnologies (ADPT) Leases (2020 - 2025)
Historic Leases for Adaptive Biotechnologies (ADPT) over the last 6 years, with Q3 2025 value amounting to $42.0 million.
- Adaptive Biotechnologies' Leases fell 976.14% to $42.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.0 million, marking a year-over-year decrease of 976.14%. This contributed to the annual value of $45.8 million for FY2024, which is 1214.87% down from last year.
- Latest data reveals that Adaptive Biotechnologies reported Leases of $42.0 million as of Q3 2025, which was down 976.14% from $43.3 million recorded in Q2 2025.
- Over the past 5 years, Adaptive Biotechnologies' Leases peaked at $92.1 million during Q2 2021, and registered a low of $42.0 million during Q3 2025.
- Over the past 5 years, Adaptive Biotechnologies' median Leases value was $77.1 million (recorded in 2023), while the average stood at $68.2 million.
- Per our database at Business Quant, Adaptive Biotechnologies' Leases soared by 18496.36% in 2021 and then plummeted by 3817.68% in 2024.
- Quarter analysis of 5 years shows Adaptive Biotechnologies' Leases stood at $87.7 million in 2021, then decreased by 7.89% to $80.8 million in 2022, then plummeted by 35.5% to $52.1 million in 2023, then fell by 12.15% to $45.8 million in 2024, then dropped by 8.26% to $42.0 million in 2025.
- Its Leases was $42.0 million in Q3 2025, compared to $43.3 million in Q2 2025 and $44.0 million in Q1 2025.